Latest Breaking News On - Burns mcclellan inc - Page 4 : comparemela.com

Intra-Cellular Therapies Inc : Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

Intra-Cellular Therapies Inc : Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCameron radinovicJuan sanchezCorporate communicationsExchange commissionBurns mcclellan incCellular therapies incCellular therapiesSharon matesQuarter financial highlightsMajor depressive disorderMontgomery asberg depression rating scaleConference callAdverse reactionsElderly patientsDementia related psychosis

vTv Therapeutics (VTVT) Reports Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon

vTv Therapeutics (VTVT) Reports Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Selina husain robert flammDburns mcclellanLee rothPaul sekhriCantex pharmaceuticals incTv therapeuticsvtv therapeutics incTv therapeutics incBurns mcclellan incGeorgetown universityCantex pharmaceuticalsChief executive officerInc cantex pharmaceuticalsLooking statementsthisAnnual reportRobert flamm

vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline

vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lee rothSelina husain robert flammDburns mcclellanPaul sekhriTv therapeutics incBurns mcclellan incTvtherapeutics incGeorgetown university for azeliragonGeorgetown universityCantex pharmaceuticals incIntellectual propertyPotential treatmentCancer related cognitiveCantex pharmaceuticalsChief executive officerAnnual report

VTv Therapeutics : Announces 2023 First Quarter Financial Results and Provides Corporate Update - Form 8-K

vTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update HIGH POINT, N.C. - May 11, 2023 - vTv Therapeutics Inc. , a. | May 11, 2023

Selina husain robert flammPaul sekhriDburns mcclellanLee rothBurns mcclellan incResearch development rd expensesTv therapeutics incQuarter financial resultsProvides corporate updateChief executive officerCash positionNet lossRedeemable noncontrolling interestStockholder deficitCommon stockConsolidated statements

Intra-Cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update

04.05.2023 - Q1 2023 total revenues of $95.3 million, compared to $35.0 million in the same period in 2022 CAPLYTA Q1 2023 net product sales were $94.7 million, compared to $34.8 million for the same period in 2022, representing a 173% increase Q1 2023 CAPLYTA .

United statesJuan sanchezCameron radinovicCorporate communicationsCellular therapies incExchange commissionBurns mcclellan incCellular therapiesSharon matesQuarter financial highlightsMontgomery asberg depression rating scaleConference callAdverse reactionsElderly patientsDementia related psychosisBoxed warning